



Therapeutic classes inducing this adverse event
BRAF inhibitor, Antiangiogenic agent, MEK inhibitor, SMO inhibitor, EGFR inhibitor
CTCAE V5.0
Present
SIMPLIFIED GRADING
Present
References
Peuvrel L, Cassecuel J, Bernier C, Quéreux G, Saint-Jean M, Le Moigne M, Frénard C, Khammari A, Dréno B; Supported by GESTIM Nantes group of cutaneous adverse events induced by cancer treatments. TOXICAN: a guide for grading dermatological adverse events of cancer treatments. Support Care Cancer. 2018;26:2871-7.
Browse for more adverse events